Page 724 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 724

Hemodialysis and Extracorporeal Blood Purification  711



             61. Francey T, Benitah N, Pantaleo V, et al. Use of combined  84. Jaeger JQ, Mehta RL. Assessment of dry weight in
                hemoperfusion  and  hemodialysis  in  accidental     hemodialysis:  an  overview.  J  Am  Soc  Nephrol
                enrofloxacin overdose. 2004 ACVIM Forum Proceedings  1999;10:392–403.
                2004;18:441–2.                                   85. Jaffrin MY, Fenech M, de Fremont JF, et al. Continuous
             62. Francey T, Cowgill LD. Use of hemodialysis for the  monitoring of plasma, interstitial, and intracellular fluid
                management of ARF in the dog: 124 cases (1990-       volumes in dialyzed patients by bioimpedance and hemat-
                2001). J Vet Intern Med 2002;16:352.                 ocrit measurements. ASAIO J 2002;48:326–33.
             63. Goldfarb-Rumyantzev AS, Cheung AK, Leypoldt JK.  86. Johnson WJ, Hagge WW, Wagoner RD, et al. Effects of
                Computer simulation of small-solute and middle-mole-  urea loading in patients with far-advanced renal failure.
                cule removal during short daily and long thrice-weekly  Mayo Clin Proc 1972;47:21–9.
                hemodialysis. Am J Kidney Dis 2002;40(6):1211–8.  87. Kanagasundaram NS, Greene T, Larive AB, et al. Prescrib-
             64. Gotch FA. Evolution of the single-pool urea kinetic  ing an equilibrated intermittent hemodialysis dose in
                model. Semin Dial 2001;14:252–6.                     intensive care unit acute renal failure. Kidney Int
             65. Gotch FA. Is Kt/V urea a satisfactory measure for dosing  2003;64:2298–310.
                the newer dialysis regimens? Semin Dial 2001;14:15–7.  88. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C,
             66. Gotch FA, Levin NW. Daily dialysis: the long and the  Lazarus JM, et al. Cardiac arrest and sudden death in
                short of it. Blood Purif 2003;21(4–5):271–81.        dialysis units. Kidney Int 2001;60(1):350–7.
             67. Gotch FA, Panlilio FM, Buyaki RA, et al. Mechanisms  89. Kazory A, Ross EA. Emerging therapies for heart failure:
                determining the ratio of conductivity clearance to urea  renal mechanisms and effects. Heart Fail Rev 2010;
                clearance. Kidney Int Suppl 2004;S3–S24.             (Aug 3).
             68. Grollman EF, Grollman A. Toxicity of urea and its role in  90. Krivitski NM, Kislukhin VV, Snyder JW, MacGibbon DR,
                the  pathogenesis  of  uremia.  J  Clin  Invest      Kuznetsova OA, Reasons AM, et al. In vivo measurement
                1959;38:749–54.                                      of hemodialyzer fiber bundle volume: theory and valida-
             69. Guh JY, Yang CY, Yang JM, et al. Prediction of      tion. Kidney Int 1998;54(5):1751–8.
                equilibrated postdialysis BUN by an artificial neural  91. Kuhlmann MK. Phosphate elimination in modalities of
                network in high-efficiency hemodialysis. Am J Kidney  hemodialysis  and  peritoneal  dialysis.  Blood  Purif
                Dis 1998;31:638–46.                                  2010;29(2):137–44.
             70. Hakim RM, Breyer J, Ismail N, et al. Effects of dose of  92. Kuhlmann U, Goldau R, Samadi N, et al. Accuracy and
                dialysis on morbidity and mortality. Am J Kidney Dis  safety of online clearance monitoring based on conductiv-
                1994;23:661–9.                                       ity variation. Nephrol Dial Transplant 2001;16:1053–8.
             71. Hakim RM, Depner TA, Parker 3rd TF. Adequacy of  93. Lambie SH, McIntyre CW. Developments in online mon-
                hemodialysis. Am J Kidney Dis 1992;20:107–23.        itoring of haemodialysis patients: towards global assess-
             72. Heidenheim AP, Muirhead N, Moist L, et al. Patient  ment  of  dialysis  adequacy.  Curr  Opin  Nephrol
                quality of life on quotidian hemodialysis. Am J Kidney  Hypertens 2003;12:633–8.
                Dis 2003;42:36–41.                               94. Langston CE. Acute renal failure caused by lily ingestion
             73. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodial-  in six cats. JAVMA 2002;220:49–52.
                ysis and patient mortality. Kidney Int 1996;50:550–6.  95. Langston CE. Acute Uremia. In: Ettinger SJ, Feldman CE,
             74. Henle T, Miyata T. Advanced glycation end products in  editors. Textbook of Veterinary Internal Medicine.
                uremia. Adv Ren Replace Ther 2003;10:321–31.         Philadelphia: Saunders Elsevier; 2010. p. 1969–84.
             75. Henrich WL. Hemodynamic instability during hemodial-  96. Langston CE, Cowgill LD, Spano JA. Applications and
                ysis. Kidney Int 1986;30:605–12.                     outcome of hemodialysis in cats: a review of 29 cases.
             76. Hemodialysis Adequacy 2006 Work Group . Clinical Prac-  J Vet Intern Med 1997;11:348–55.
                tice Guidelines for Hemodialysis Adequacy, Update 2006.  97. Lesaffer G, De Smet R, D’Heuvaert T, et al. Comparative
                Am J Kidney Dis 2006;48(Suppl. 1):S2–S90.            kinetics of the uremic toxin p-cresol versus creatinine in
             77. Herget-Rosenthal  S,  Glorieux  G,  Jankowski  J,   rats with and without renal failure. Kidney Int
                Jankowski V. Uremic toxins in acute kidney injury. Semin  2003;64:1365–73.
                Dial 2009;22(4):445–8.                           98. Levine J, Bernard DB. The role of urea kinetic modeling,
             78. Himmelfarb J, Chuang P, Schulman G. Hemodialysis. In:  TACurea, and Kt/V in achieving optimal dialysis: a critical
                Brenner BM, editor. Brenner &Rector’s the kidney.    reappraisal. Am J Kidney Dis 1990;15:285–301.
                Philadelphia: Saunders Elsevier; 2007. p. 1957–2006.  99. Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treat-
             79. Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use  ment dose for novel therapies using urea standard Kt/V.
                of hemodialysis and hemoperfusion in poisoned patients.  Semin Dial 2004;17(2):142–5.
                Kidney Int 2008;74(10):1327–34.                 100. Lindsay RM, Leitch R, Heidenheim AP, et al. The
             80. Huang Z, Gao D, Letteri JJ, Clark WR. Blood-membrane  London Daily/Nocturnal Hemodialysis Study—study
                interactions  during  dialysis.  Semin  Dial  2009;22  design, morbidity, and mortality results. Am J Kidney
                (6):623–8.                                           Dis 2003;42:5–12.
             81. Huang Z, Letteri JJ, Ronco C, Clark WR. Basic principles  101. Locatelli F, Buoncristiani U, Canaud B, Ko ¨hler H,
                of solute transport. In: Kellum JA, Bellomo R, Ronco C,  Petitclerc T, Zucchelli P. Dialysis dose and frequency.
                editors.  Continurous  Renal  Replacement  Therapy.  Nephrol Dial Transplant 2005;20(2):285–96.
                New York: Oxford University Press; 2010. p. 25–32.  102. Locatelli F, Buoncristiani U, Canaud B, et al.
             82. Ikizler TA, Schulman G. Adequacy of dialysis. Kidney Int  Haemodialysis with on-line monitoring equipment: tools
                Suppl 1997;62:S96–S100.                              or toys? Nephrol Dial Transplant 2005;20:22–33.
             83. Ishibe S, Peixoto AJ. Methods of assessment of volume  103. Locatelli F, Covic A, Chazot C, et al. Optimal composi-
                status and intercompartmental fluid shifts in hemodialysis  tion of the dialysate, with emphasis on its influence on
                patients: implications in clinical practice. Semin Dial  blood  pressure.  Nephrol  Dial  Transplant
                2004;17:37–43.                                       2004;19:785–96.
   719   720   721   722   723   724   725   726   727   728   729